Package 65862-692-78

{"route": ["ORAL"], "spl_id": "8b54186e-7485-40f0-8fe0-58b417dfcb7e", "openfda": {"unii": ["4182431BJH"], "rxcui": ["855671"], "spl_set_id": ["5362ea50-38a4-48b4-a85b-d634c3d8b91a"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (65862-692-01)", "package_ndc": "65862-692-01", "marketing_start_date": "20150610"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (65862-692-78)  / 10 CAPSULE in 1 BLISTER PACK (65862-692-10)", "package_ndc": "65862-692-78", "marketing_start_date": "20150610"}, {"sample": false, "description": "1000 CAPSULE in 1 BOTTLE (65862-692-99)", "package_ndc": "65862-692-99", "marketing_start_date": "20150610"}], "brand_name": "Extended Phenytoin Sodium", "product_id": "65862-692_8b54186e-7485-40f0-8fe0-58b417dfcb7e", "dosage_form": "CAPSULE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "65862-692", "generic_name": "Phenytoin Sodium", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Extended Phenytoin Sodium", "active_ingredients": [{"name": "PHENYTOIN SODIUM", "strength": "100 mg/1"}], "application_number": "ANDA204309", "marketing_category": "ANDA", "marketing_start_date": "20150610", "listing_expiration_date": "20261231"}